I found this on the DrugChannels.net blog. A good visual of the data showing how “productivity” has improved per location by different types of pharmacies.
What I think is interesting is that mass merchants have stayed flat. With Target’s original couponing strategy and Wal-Mart’s $4 generics, you would have assumed those had an impact that would show up here. I’m guessing the lift at independents could be explained away with increased utilization so the same number of patients go to the stores with just more scripts.
I’m not sure I have the time (or if the data is even available), but it would be interesting to look at patients per location and Rxs per pharmacist (and per pharmacy tech) by type of pharmacy.
No comments yet... Be the first to leave a reply!